RAPS Workshop: US Regulation of Advertising and Promotion for Medical Devices (December 2025)

Hear from industry leaders, regulatory experts, and legal professionals as they share their expertise on medical device advertising, promotion, and labeling in the US.

Through presentations, discussions and case studies, this virtual program will examine current guidelines and expectations for medical devices and how they impact the way you communicate with prospective and end users.

Registration Fees & Deadlines

Learning Objectives

After this program, participants will be able to:

• Summarize regulations, enforcement actions, guidelines and trends affecting the advertising and promotion of medical devices
• Identify key regulatory issues surrounding complex and rapidly shifting hot topics in advertising and promotion, with specific attention on FDA’s regulation of social media promotion
• Examine the current state of off-label promotion
• Evaluate and use real-world data (RWD) and real-world evidence (RWE) in promotion
• Discover regulatory applications through case studies
• Explore the Federal Trade Commission oversight of advertising and promotion
• Learn more broadly about healthcare regulation of device company interactions with providers, including fraud and abuse and the False Claims Act
• Discuss proactive good promotional practices designed to ensure compliance including the use of medical advisory committees

Who Should Attend?

Early to mid-level regulatory professionals involved in advertising and promotion of medical devices for the US market.

• Regulatory consultants
• Compliance specialists
• Food, drug, and medical device attorneys
• Marketing representatives
• Medical communications professionals
• Medical affairs
• Medical writing
• Medical Science Liaisons (MSLs)
• Clinical research professionals

Audience Learning Level

Basic: Content is introductory in nature and requires no requisite knowledge or experience to grasp concepts and related exercises. Basic educational activities are meant to establish a foundation of knowledge and/or competence that will be expanded upon in practice or in higher level activities.

Agenda

Speakers

Jessica Ringel
Partner, FDA Life Sciences, King & Spalding

Jessica Ringel advises medical devices, pharmaceutical, HCT/P, and cosmetics manufacturers and distributors on matters involving FDA regulation. Jessica’s postmarket practice focuses on safety and quality matters, including responses to FDA inspections and enforcement actions, recall and adverse event matters, and advertising and promotion. Her pre-market practice includes advising on regulatory strategy and marketing applications. Jessica’s transactional practice involves conducting due diligence evaluations of life sciences targets for manufacturers, private equity firms, and investment banks.

Alan G. Minsk
Partner, Head of Food & Drug Team, Arnall Golden Gregory LLP

Cancellations and Refunds

RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to support@raps.org. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.

Substitutions

Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email support@raps.org with the event title, name of the original registrant and the contact information for the new attendee.

Proof of Attendance

A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.

Questions